








The effect of cellular growth, metabolism, and monoclonal antibody production on an 
industrial GS-NS0 cell line to hyper-osmotic medium was studied.  The GS-NS0 cell 
line was found to have an optimum growth rate at a medium osmolality of 350 
mosm/kg and an optimum specific productivity at 450 mosm/kg.  Medium osmolality 
was shown to affect cell size as the cell line exhibited a regulatory cell volume 
increase response after an initial introduction into hyper-osmotic conditions.   
The response of the cell line to an osmotic shift was also studied.  Osmolality of the 
culture medium was increased, at two different time points, through the addition of 
NaCl.  The shift in osmotic pressure was found to have a positive impact on specific 
productivity of the monoclonal antibody produced.   
A finger print of the metabolic response of the GS-NS0 cell line to increased medium 
osmolality was determined.  The application of metabolomics to mammalian cell 
cultures has not been widely explored.  In this study, the cells were quenched and 
extracted using methods previously developed for microbial and plant cultures.  An 
increase in concentration of internal amino acids, known to be osmolytes, was found 
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Chapter 1 Introduction and Overview 
 
 
1.1 Problem Description and Motivation 
 
This work focuses on the response of an industrial, monoclonal antibody producing 
GS-NS0 cell line to increased medium osmolality.  In the biopharmaceutical industry, 
much research is dedicated to learn how the cell’s environment, such as osmolarity, 
temperature, and pH, impact cell growth and antibody production.  A clear 
understanding of the ideal environmental parameters will allow for the optimum 
production of marketable antibodies.  The osmolarity of a cell’s environment greatly 
impacts the metabolism of the cell and in turn the cell’s ability to produce antibodies.  
Osmolarity can be easily and cheaply altered during industrial production, thus 
knowledge of how osmolarity can positively impact antibody production can be 
financially beneficial for a company.     
Osmolarity (or osmolality) is a measurement of the moles of a solute that contribute 
to the osmotic pressure of a solution, thus if a solution consists of 1 mol/L of glucose, 
the osmolarity would be 1 osmol/L.  However, in the case of ionic compounds which 
disassociate in water, the osmolarity is determined by the number of disassociated 
species; therefore, 1 mol/L of NaCl would correspond to an osmolarity of 2 osmol/L.  
Osmolarity is measured in the units of osmoles per unit volume, while osmolality is 
measured in the units of osmoles per unit mass.  The analytical equipment used 
during the execution of this work calculated the solute concentration in terms of 
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This thesis work can essentially be divided into three topics each with their own 
significance.  The first set of experiments (Chapters 4 and 5) give an insight into the 
industrial cell lines response to hyperosmotic conditions.  At HGS, research into a cell 
line’s response to hyperosmolarity had not been previously examined.  While the 
results are similar to findings reported for other cell lines, this experimentation gave 
us the ability to gain metabolic parameter data pertinent to a developmental cell line.   
The second set of experiments (Chapter 6) looked at altering the cellular environment 
in order to increase antibody production.  It was found that increasing the osmolality 
of the cell culture during the production process can be beneficial to the antibody 
production rate.   
The last experiment (Chapter 7) examined the use of metabolomics to further 
understand the effect of osmolality on the intracellular metabolites of the cell.  This 
technique is not routinely performed on mammalian cell culture.  In these 
experiments, we found that the intracellular metabolite concentration was indeed 
impacted by the environmental osmolality.  The findings correlate to osmotic 
responses seen in other cell types. 
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1.3 Overview of Chapters  
 
Chapter 2 covers a brief background divided into three sections: 1. monoclonal 
antibodies, 2. osmolality effects on cell culture, and 3. metabolomics.  In the 
monoclonal antibodies subsection, information on the structure and function of 
antibodies is described.  An overview of the industrial cell lines used to produce 
antibodies is given as well as marketing economics of antibodies as therapeutics.  In 
the second subsection, a brief overview of the general osmolality effects on cell 
culture is introduced.  Further discussion of the impact of osmolality on metabolism 
and antibody production is given in the introduction section of the subsequent 
chapters describing the experimental research.  In the third background section, a 
brief introduction to metabolomics and the tools used for this analysis is described.   
Chapter 3 describes the cell line, medium, and analytical methods used throughout 
the cell culture experiments.    
Chapters 4 through 7 cover the different experiments performed.  Each chapter 
includes an introduction with background information relevant to the topic as well as 
the methods used to perform the experiment, and the results, discussion, and 
conclusions for each experiment.   
Chapter 8 concludes the highlights and overall findings of this research. 
The last chapter, 9, discusses future studies that can be performed to gain additional 
insight into this topic. 
4 
Chapter 2 Background 
 
 
2.1 Monoclonal Antibodies 
 
2.1.1 Antibody Structure and Function 
 
Antibodies are produced by the body as a response to an antigen, a foreign particle, 
or infectious agent.  After the introduction of an antigen, B lymphocyte cells multiply 
and produce an antibody to the antigen.  The antibody contains a specific binding site 
that recognizes a specific site on an antigen, termed an epitope.  Monoclonal 
antibodies (mAbs) are antibodies that are produced from one particular B lymphocyte 
and its cloned cells.  Monoclonal antibodies are specific to one epitope region on the 
antigen.  However in an immune response in the animal body, multiple different B 
lymphocyte cells produce different antibodies, which bind to different regions on the 
antigen.  The collection of all the antibodies produced due to the immune response is 
termed polyclonal antibodies (Lodish, 2000).   
Antibodies consist of two large (heavy, H) and two small (light, L) polypeptide chains 
which are paired together as shown in Figure 2-1.  Sequence analysis of antibodies 
found that both the heavy and light chain comprise of regions of variable sequence at 
the N-terminus and constant regions at the C-terminus (Karu, 1995).  Antibodies have 
been divided into subclasses based on the structure and function of the constant 
regions.   
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Taken From:  http://www.abcam.com/index.html?pageconfig=resource&rid=11258&pid=11287 
Figure 2-1.  Antibody structure 
 
Digestion of the antibody by the proteolytic enzyme papain found that three 
fragments are produced.  Two of the fragments retain the antigen binding region and 
are termed Fab fragments (Elgert, 1996).  The third fragment, termed Fc, consists of 
the heavy chain constant regions, CH2 and CH3 (Figure 2-1).   
Further digestion of the Fab fragments can generate Fv fragments which consist of 
only the variable domains of the heavy and light chains (Figure 2-2).  Fv fragments 
are the smallest antibody structure than can preserve the antigen binding region 
(Karu, 1995).  It is these variable regions which give the ability for immune responses 




Figure 2-2.  Antibody fragments 
 
The variable region of both the heavy and light chains is further divided into regions 
called hypervariable or complementarity-determining regions (CDR).  The CDR 
regions are linked together by intervening sequences termed the framework residues 
(FR) (Figure 2-3).  Framework residues compose of approximately 85% of the 
variable region (Elgert, 1996).  When the light chain and heavy chain bind together, 




Figure 2-3.  Location of the FR and CDR regions on the Fab 
 
 
Figure 2-4.  CDR regions of antibodies 
 
2.1.2 Antibody Engineering 
 
In 1975, KohIer and Milstein described a method for making cell lines for secreting 
monoclonal antibodies (Kohler, 1975).  Normal antibody producing mouse spleen 
cells are fused to myeloma cells in order to produce an immortal clone termed a 
hybridoma (Lodish, 2000).  However, the mouse antibodies when introduced to 
humans caused immunogenic issues which limited their use as a therapeutic (Spier, 
2000).  In 1984, Morrison et al. described the genetic engineering of chimeric mAbs, 
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a fusion of a mouse variable region with a human constant region.  These mAbs have 
also seen an immunogenic response in humans (Kim, 2005).   
Due to immunogenic responses, the use of more human-like mAb fragments was 
desired for therapeutics.  CDR-grafting is used to produce “humanized” mAbs, where 
the CDR loops that are responsible for antigen binding are grafted onto human FR.  
However, CDR-grafting has often resulted in loss of the affinity for the humanized 
mAb to bind to the antigen (Kim, 2005). 
The next move for antibody engineering was the development of a fully human mAb.   
Today, fully-humanized mAbs are mostly generated by one of two procedures:  1.  
phage display technology (Hudson, 2003), or 2.  XenoMouse technology (Jakobovits, 
2007).   
2.1.3 Cell Line Selection and Formation 
 
To express the developed antibody, the DNA needs to be added to a plasmid and in 
turn introduced into a cell line.  The most common cell lines used for antibody 
expression in industry are from yeast, mouse, or human sources.  However, 
mammalian cell lines are used more frequently to express antibodies as therapeutics, 
due to glycosylation patterns formed during post-modification of proteins.  The 
mammalian cell lines commonly used in industry include Chinese hamster ovary cell 
line, CHO; non-secreting mouse myeloma cell line, NS0; and a human retina derived 
cell line, Per.C6 (Table 2-1).   
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Table 2-1. Pros and cons of cell line s ource  
Characteristic  CHO NS0 Per.C6 
FDA Approved mAbs Yes Yes None 
Glycosylation Human-like Human-like Human 
Human Viral Issues None None Yes 
Cholesterol Dependence during Cell 
Culture Process None Yes None 
 
 
2.1.4 Market for Industrial Produced Monoclonal Ant ibodies 
 
The industrial production of mAbs is a multi-billion dollar worldwide market.  Between 
2001 and 2002, the global therapeutic mAb market was $5.4 billion (Reichert, 2004).  
In 2006, the market grew to over $20 billion (Maggon, 2007).  The mAbs tend to be 
developed for chronic conditions such as cancer and autoimmune disorders as well 
as infectious diseases (Table 2-2).  These indications and the low potency of mAbs 
result in large doses and high costs (upwards of $35,000) for the patients (Farid, 
2007).   
To reduce the treatment cost for the patient, industry needs to reduce manufacturing 
costs from its current $1000 per gram to a more economical $100 per gram or less 
(Farid, 2007).  In order to decrease manufacturing costs, companies try to produce 
mAbs at the largest scale possible.  Companies such as Genentech and Amgen are 
running commercial bioreactors at the 20,000 L scale.  However, increasing the 
bioreactor size does not necessarily reduce patient cost significantly.  The cost of 
goods for manufactured mAbs is still reported to be 20-25% of sales (Farid, 2007).  
Developing ways to reduce the cost of goods could help to drastically reduce the 
patient cost drastically.   
 
10 
Table 2-2.  Therapeutic mAbs approved in the United  States* 
Company  Generic Name  US Trade Name  mAb Type  Indication  
Johnson & Johnson Muromonab-CD3 Orthoclone OKT3 Murine Transplantation 
Centocor Abciximab ReoPro Chimeric Cardiac ischemic 
Biogen IDEC Rituximab Rituxan Chimeric RA, NHL 
Protein Design Labs Daclizumab Zenapax Humanized Prophylaxis 
Novartis Basiliximab Simulect Chimeric Prophylaxis 
MedImmune Palivizumab Synagis Humanized RSV 
Centocor Infliximab Remicade Chimeric RA 
Genentech Trastuzumab Herceptin Humanized Caner 
Wyeth Gemtuzumab 
ozogamicin 
Mylotarg Humanized Leukemia 
Millinnium/ILEX Alemtuzumab Campath Humanized Leukemia 
Biogen IDEC Ibritumomab tiuxetan Zevalin Murine NHL 
Abbott Adalimumab Humira Human RA 
Genentech Omalizumab Xolair Humanized Asthma 
Corixa Tositumomab-I131 BEXXAR Murine NHL 
Genentech Efalizumab Raptiva Humanized Psoriasis 
Imclone Systems Cetuximab Erbitux Chimeric Skin Cancer 
Genetech Bevacizumab Avastin Humanized Cancer 
* Based on (Reichert, 2004) 
A majority of commercial cell lines produce mAbs at the 1 – 2 g/L concentration.  If a 
cell line’s productivity could be doubled, the cost of goods for the commercial 
production could be reduced in half.  Process development efforts, such as, 
determining process operation set points, batch and feed medium composition, and 
feeding strategies, can drastically increase productivity.  Typical mammalian culture 
utilizes process operation set points that mimic the intracellular conditions of the 
mammalian cell:  pH of 7, temperature of 37oC, and osmolality of 290 – 320 
mosm/kg.  Deviations from the intracellular conditions have been shown to produce 
stresses on the mammalian cell culture and these stresses have been shown to 




2.2 Osmolality Effect on Cell Culture 
 
Typically, cells have an internal osmolality of 270 – 300 mosm/kg (Duncan, 1997).  
Mammalian cells maintain their internal osmolality through osmoregulation.  If a cell is 
introduced into a hypo-osmotic environment, water will move into the cell; if a cell is 
placed in a hyper-osmotic environment, water will move out of the cell into the 
solution with a greater ionic strength (Alberts, 1994).  In both cases, the cell quickly 
acts to return the internal osmolality to natural conditions by controlling the uptake 
and release of ions and charged molecules.    
Cells contain the ability to regulate their cellular volume.  Changes in cell volume 
(size) are mainly caused by osmotic pressure gradients across the cell membrane 
(Lang, 1998 a.).  When cells are exposed to hypo-osmotic conditions, they will initially 
swell and when exposed to hyper-osmotic conditions, they will initially shrink.  In both 
cases, the cells will eventually return to the original cell volume through regulatory 
cell volume decrease (RVD) or increase (RVI) (Lang, 1998 b.; Erickson, 2001).  Since 
the increase or decrease of ions, Na+, Cl-, HCO3-, K+, contributes to the osmotic 
pressure gradients across a membrane, ion transport across the cell membrane is of 
great importance in regulation of cell volume (Lang 1998 a.).   
The accumulation of electrolytes, during RVI, after cell shrinkage, is limited because 
high ion concentrations interfere with the structure and function of proteins in the cell 
(Yancey, 1982).  It has been reported that levels of intracellular K+ vary slightly 
despite large changes in medium osmolality (Lin, 1999 b.).  For a cell to return to its 
original volume, cells produce or uptake osmolytes, molecules which create 
osmolality without compromising cell function (Handler, 1993; Kinne, 1993), as a 
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secondary means of osmotic control.  Osmolytes shown to be key to regulating cell 
volume include, polyalcohols, such as sorbitol and inositol, methylamines, such as 
betaine, and amino acids and amino acid derivatives, such as glycine, glutamine, 
glutamate, aspartate, and proline (Burg, 1994; Garcia-Perez, 1991; Kinne, 1993; 
Lang 1998 b.; Chua, 1994).  The cellular accumulation of osmolytes for cells cultured 
in hyper-osmotic conditions has been shown to help them proliferate in the 
environment (Yancey, 1990). 
2.3 Metabolomics 
 
Process development improvements to increase cell growth and productivity have 
mainly been from hit or miss experimentation or design of experiment analysis by 
altering growth conditions.  Advances in systems biology techniques, such as 
metabolomics, the quantification of intracellular metabolites, can increase the 
understanding of how these process changes enhance cellular performance.  
Metabolomics can provide a deeper insight into relevant biochemical pathways and 
their regulations; this can lead to improved production processes by increasing mAb 
formation and reducing byproduct accumulation.  Metabolomics can provide a clearer 
understanding of substrate consumption, product formation, and cellular energy 
management which can increase productivity and subsequently reduce mAb 
production costs (Oldiges, 2007).  Overall the application of metabolomics in the area 
of mammalian cell culture is relatively undeveloped (Khoo, 2007).   
The first step of metabolomics, quenching of the cell’s metabolism, is the most crucial 
to ensuring an accurate profile of the intracellular metabolites.  Quenching is the rapid 
stopping of the enzymatic activity and subsequent changes to the metabolic levels.  
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Currently, there is no established method for quenching mammalian cells in 
suspension culture (Oldiges, 2007).  Basic techniques for quenching metabolism in 
other cell types include chilling the sample in cold methanol (Villas-Boas, 2005), 
snap-freezing in liquid nitrogen (Griffin, 2000) and acid treatments (Mashego, 2007).  
These methods tend to be time consuming and laborious and can lead to a 
degradation of the metabolites. Methods such as spray freezing into cold methanol 
during continuous sampling (Buchlolz, 2002) can expedite the sampling and 
quenching process.  Recently, Wiendahl et. al (2007) has designed a micro heat 
exchanger to quench the metabolism of mammalian cells in order to improve the 
sampling procedure and obtain better quantification of metabolites. 
After quenching, the next step is extracting the intercellular metabolites.  Frozen cell 
samples are either homogenized or sonicated in the presence of organic and/or non-
organic solvents in order to release the polar and non-polar metabolic compounds 
(Khoo, 2007).  The mixture of cell debris and extracted metabolites is then 
centrifuged or filtered to separate the liquid containing the desired metabolites. 
Once the metabolites have been extracted from the cells they are next separated and 
identified.  Traditional procedures of gas-chromatography mass spectrometry (GC-
MS) and liquid chromatography mass spectrometery (LC-MS) and new techniques of 
capillary-electrophoresis mass spectrometry (CE-MS) and Fourier transform ion 
cyclotron resonance mass spectrometry (FTICR-MS) are being used to rapidly 









3.1.1 GS-NS0 Cell Line  
 
A cholesterol dependent, GS-NS0 mouse myeloma cell line producing a human mAb 
was used for the execution of these experiments.  The GS-NS0 cell line was 
transfected with the glutamine synthetase selectable marker.  Glutamine synthetase 
is an enzyme that catalyzes the conversion of glutamate and ammonia to glutamine.  
NS0 cell lines containing this selectable marker are grown without the presence of 
glutamine.   
3.1.2 Growth and Production Media  
 
A commercially available basal growth medium without L-glutamine was used as the 
batch medium.  The commercial medium is protein-free and chemically defined and 
contains a proprietary blend of glucose, amino acids (except L-glutamine), and salts 
that have been shown to support growth in hybridoma and myeloma cell lines.  Since 
the GS-NS0 cell line used for these studies was cholesterol dependent, a 
concentrated cholesterol suspension was added to support cell growth. 
For fed-batch cultures, a proprietary complex feed medium (HGS) was used to 
support cell growth beyond the batch phase.  The feed medium was supplemented 
with cholesterol which is required for the cell line. 
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3.2 Analytical Methods 
 
3.2.1 Cell Density and Cell Viability 
 
Cell density and cell viability were measured using a CEDEX Cell Counter 
(Innovatis).  The CEDEX cell counter performs an automated trypan blue exclusion 
assay on a cell culture sample.  The instrument takes multiple images of the cell 
culture sample and then quantifies the live (non-stained) and dead (stained) cells.  A 
total cell number and cell viability is determined for each image by the ratio of live 
cells to total cells.  A cell culture sample’s viable cell density (VCD), total cell density 
(TCD), and viability is reported as an average of the values of all the images taken. 
3.2.2 Glucose and Lactate Measurements 
 
Glucose and lactate concentrations in the culture medium were measured using an 
YSI 2700 (Yellow Springs International).  The YSI 2700 uses an enzymatic reaction 
to determine the concentration of glucose or lactate in the sample.  An immobilized 
enzyme, either glucose oxidase or lactate oxidase, is located between two 
membranes.  Glucose (or lactate) is then oxidized after it crosses the membrane and 
produces hydrogen peroxide.  The hydrogen peroxide is subsequently oxidized and 
produces a current that is proportional to the concentration of the glucose or lactate 
concentration in the cell culture sample. 
3.2.3 Osmolality 
 
Osmolality was measured using an Advanced 2020 Multi-sampler Osmometer 
(Advanced Instruments).  This osmometer measures the osmolality (concentration of 
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particles per mass of solution) by the freezing point depression method.  The extent 
to which a solvent’s freezing point has been decreased is a direct measure of the 
concentration of particles in the solution. 
3.2.4 pH 
 
pH measurements were conducted with a Rapid Lab 240 Blood Gas Analyzer (BGA) 
(Bayer).  The BGA is primarily used in the healthcare industry to measure the 
concentration of pO2 and pCO2 as well as pH in blood samples; however it has 
routine use in the biopharmaceutical industry to measure these quantities in 
mammalian cell culture samples. 
3.2.5 mAb Concentration 
 
The concentration of mAb in cell culture samples was determined by a high 
performance-liquid chromatography (HPLC) method using an affinity column.  The 
mAb binds to an antigen that is attached to the column beads.  The antibody is then 
eluted off the column and the concentration of the mAb peak is determined by the 







Chapter 4 Effect of Osmolality on Cell Growth, Gluc ose 





Typical cell culture medium has an osmolality of 270 to 300 mosm/kg (Duncan, 
1997).  Under these conditions, the cell culture tends to have the highest growth rate, 
µ.  Hyper-osmotic conditions have been shown to decrease µ (Chua, 1994; Wu, 
2004; Ozturk, 1991) and  increase glucose consumption rates, νG and lactate 
production rates, qL (Table 4-1).   
To improve our understanding of the effect of medium osmolality on cell growth and 
metabolism of a GS-NS0 cell line at HGS, we evaluated µ, νG, and qL for cultures 
grown at five different osmolalities. 
Table  4-1.  Effect of osmolality on metabolic p arameters  


















































1  Values shown in Table 4-1 are interpolated from figures from Lin, 1999 b. 
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In this experiment, the effect of medium osmolality on the growth rate, glucose 
consumption, and lactate production rates of the GS-NS0 cell line was determined.  
Medium osmolalities of 290, 320, 350, 400, 450 mosm/kg were tested.  The 
osmolality of the commercial basal medium manufactured was 180 mosm/kg.  NaCl 
was supplemented to the medium to achieve the desired osmolality.  Previous 
studies have shown that the effect of medium osmolality on cell growth and 
metabolism was independent of electrolyte used to increase osmolality (Chua, 1994).  
4.2 Methods 
 
Basal medium was prepared with five different osmolalities, 290, 320, 350, 400, and 
450 mosm/kg, by adjusting the concentration of NaCl in the medium.  Synthetic 
cholesterol was added to the basal medium. 
A GS-NS0 cell culture, initially grown at approximately 300 mosm/kg, was obtained 
for use as an inoculum for this experiment.  The inoculum culture was added to each 
medium at a starting viable cell density (VCD) of 2.0 x 105 cells/mL.  The cultures 
were grown in 250 mL shake flasks with a working volume of 125 mL.  Operating 
conditions for the incubator were:  115 rpm, 37oC, 80% relative humidity (rh), and 5% 
CO2.  Once the fastest growing condition reached approximately 18 to 20 x 10
5 
cells/mL, all the shake flasks were passaged into fresh medium of the same 
osmolality.  Four passages were performed.  Each condition was performed in 
duplicate.   
Samples were taken daily to measure VCD, viability, glucose and lactate 
concentration, pH, and osmolality of the cultures.  The time course data was used to 
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calculate the following metabolic parameters during exponential growth: glucose 
consumption rate, lactate production rate, and cellular growth rate. 
4.3 Results  
 
The medium with the highest osmolality (450 mosm/kg) was shown to have the 
largest impact on the VCD of the cultures (Figure 4-1).  The cultures grown at 350 
mosm/kg were shown to produce the highest maximum VCD.   
The viability of the culture (Figure 4-2) was not affected by osmolality up to 400 
mosm/kg, thus the increase in osmolality, for the range tested, does not promote cell 
death or apoptosis.  The viability of the GS-NS0 cells cultured at 450 mosm/kg was 
reduced; however upon the fourth passage, the viability was similar to other 
conditions.  This indicates that the cells were capable of adapting to the higher 
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Figure 4-2:  Viability of the cultures during subse quent passages 
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The growth rate of the GS-NS0 cell line was found to be the highest in the 350 
mosm/kg medium (Figure 4-3).  Overall, the growth rate was significantly less in the 
450 mosm/kg medium.  Upwards of a 30% difference in growth rate can be seen 
between passages for the same osmolality condition; however, the effect of medium 
osmolality on growth rate remains independent of passage number. These 
differences can be contributed to differences in the inoculation VCD and the inherent 

























Passage 1 Passage 2 Passage 3 Passage 4
 
Figure 4-3:  Osmolality effect on growth rates duri ng batch phase.   
 
Figure 4-4 shows the glucose and lactate trends for the passages 1, 2, and 3.  The 
cultures grown at hyper-osmotic conditions consumed the greatest concentration of 
glucose and produced the highest concentration of lactate.  As the osmolality of the 
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Passage 1 Passage 2 Passage 3 Passage 4
 
Figure 4-6:  Osmolality effect on lactate productio n rates during batch phase. 
 
The average µ, νG, and qL across the passages, for each osmotic condition was 
calculated and the yield of lactate from glucose was determined (Table 4-2).  The 
grams of lactate produced per gram of glucose, YL/G, was found to increase 
throughout with increasing osmolality. This suggests that the cells were stressed at 





















µ, hr -1 0.0259 0.0273 0.0286 0.0255 0.0198 
νG, 
µmol/10 6 
cell / hr 
0.0853 0.0949 0.1027 0.1388 0.2311 
qL, 
µmol/10 6 
cell / hr 
0.0852 0.0987 0.1101 0.1567 0.2575 





0.999 1.040 1.071 1.129 1.114 
 
When the cells were initially introduced into the different osmolality media, the cell 
diameter was shown to decrease in correlation with increased osmolality (Figure 4-7).  
The 450 mosm/kg cultures were found to be 9% smaller than the cultures inoculated 
into iso-osmotic medium.  After 24 hours, the cell diameter of all the cultures had 
increased from the initial decrease.  At 48 hours, a clear correlation between cell 
diameter and medium osmolality was found; as the osmolality of the medium 
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The osmolality of the cell culture medium greatly affected the growth rate, glucose 
consumption rate, and lactate production rate of the GS-NS0 cell line (Table 4-2).  
Cultures grown at 350 mosm/kg were found to have the highest growth rate.  This 
finding is surprising as cells tend to have an internal osmolality of 270 – 300 mosm/kg 
(Duncan, 1997).  The glucose consumption rate and lactate production rates 
increased as the osmolality of the medium increased.  In the hyper-osmotic cultures, 
the increase in glucose consumption was not routed to increasing cellular mass.  
Instead, the cells showed a stress response to hyper-osmotic conditions as YL/G 
increased with increasing osmolality.  Previous research has suggested that cultures 
grown under hyper-osmotic conditions have an increase in ATP production (Lin, 1999 
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b).  The increase in glucose consumption could be correlated with an increase in 
energy requirements needed for cells to proliferate in the hyper-osmotic medium.  
The effect of medium osmolality on growth rate, glucose consumption and lactate 
production rates correlate with previous data reported by Lin (1999 b.) and Ozturk 
(1994).   
The hyper-osmotic medium did not affect the viability of the GS-NS0 culture (Figure 
4-2).  This finding is similar to results, presented by Oyaas (1994), using a hybridoma 
cell line.  Oyaas (1994) showed that the death rate, kd, for cultures grown between 
330 to 465 mosm/kg remained unchanged.   
The GS-NS0 cell line was found to possess cell volume regulatory mechanisms.  
When the cells were first introduced to hyper-osmotic conditions, the cells initially 
shrunk as a response to the osmotic pressure gradient and the loss of water (Figure 
4-7).  These findings correlate with data presented by Ozturk and Palsson (1991), 
where the hybridoma cell line they studied showed a similar decrease in cell volume 
after initial exposure to increased medium osmolality. 
However, after the initial decrease in diameter, the cells began to increase in size, as 
shown by the measurement at 24 hours (Figure 4-7).  These findings suggest that the 
cells regulate their volume based on the regulatory cell volume increase (RVI) 
mechanism described by Lang (1998 a.).  RVI proposes that cells initially shrink when 
exposed to hyper-osmotic conditions but then approach the original cell volume in 
attempts to return to a steady state.  Lang (1998 a.) reported that in order for a cell to 
return to a more natural state, they need to uptake electrolytes and osmolytes.   
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Overall, the cells grown at the highest osmotic conditions became the largest size 
through the use of regulatory mechanisms.  These findings are comparable to 
previous research on hyper-osmotic stress responses on a hybridoma cell culture 
(Ozturk, 1991).     
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Hyper-osmotic growth conditions have shown to produce higher mAb titers, over iso-
osmotic conditions, in numerous cell lines (Table 5-1).  Some studies have suggested 
the increase in ATP production in hyper-osmotic medium could be the reason for 
increased mAb production (Lin, 1999 b.).  However, the increase in mAb production 
does not necessarily correlate to an increase in total mAb produced, since the cell 
growth rates are reduced in the hyper-osmotic medium (Table 5-1, Figure 4-3).  
Further knowledge of how osmotic pressure affects the cellular metabolism will 
provide insight into an economical means of increasing industrial antibody production 
(Wu, 2004).   
To improve our understanding of how medium osmolality effects the mAb production 
of a GS-NS0 cell line at HGS, we evaluated mAb production under five different 





Table  5-1. Osmolality effect on mAb production  and growth rate from p ublished  
Cell Line Osmolality, mosm/kg 
Change  in mAb 
Production, % 
Change  in 




398 + 59.1 - 30.0 
Ozturk, 1991 




400 + 98.7 - 33.3 
Chua, 1994 
450 + 97.4 - 58.3 
GS-NS0 





Prior to the inoculation of shake flasks for the fed-batch experiment the cells were 
acclimated to different osmolalities as a result of three passages at 290, 320, 350, 
400, and 450 mosm/kg.  Cells were inoculated (passage four) into the fresh basal 
medium, with differing osmolality, at a VCD of 2.2 x 105 cells/mL.  The cells were 
grown in 500 mL shake flasks with a working volume of 325 mL.  Operating 
conditions for the incubator were:  115 rpm, 37oC, 80% rh, and 5% CO2.   
The data for growth, glucose uptake, and lactate production rates for the batch phase 
portion of the fed-batch experiment (first 72 hours) was presented in Section 4 as 
Passage 4.  On Day 3 (~72 hours), the cultures from passage 4 were fed a bolus of 
the HGS proprietary nutrient rich feed.  The cultures were then fed additional boluses 
of the proprietary nutrient rich feeds on Day 5 and 7.  Concentrated glucose (400 g/L) 
was added to the culture on days 8 through 11, when required, to bring the glucose 
concentration to 2 g/L.   
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Samples were taken daily for VCD, viability, glucose and lactate concentration, pH, 
and osmolality.  Samples retains were saved at -80C for protein quantification by 
HPLC. 











                        Eq. 1 
where xv is the viable cell density concentration and mAb is the concentration of 
antibody. 
5.3 Results  
 
The cultures grown at 290 and 320 mosm/kg produced the highest VCD (Figure 5-1), 
while culture grown at 450 mosm/kg had the lowest VCD.  This was to be expected 
based on the effect of medium osmolality on growth rate during batch phase 
experiments (Table 4-1). 
The viability of all the cultures was comparable up to 192 hours (day 8) (Figure 5-2).  
After 200 hours, the viability of the cultures grown at 450 mosm/kg remained high, 
while the viability of the lower osmolality cultures began to decrease.  Due to the 
higher viability in the 450 mosm/kg culture, the fed-batch experiment was continued 
for an additional 24 hours.  Higher viabilities in cultures grown at 450 mosm/kg were 
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Figure 5-2:  Osmolality effect on viability during the fed-batch process 
 
33 
The glucose trends for all the osmotic conditions are similar during the batch phase 
(up to 72 hours), as the osmolality of the culture increased, so did the glucose 
consumption rate (Figure 5-3).  After the first feed at 72 hours, the glucose trends for 
the cultures grown at 290 to 400 mosm/kg followed the same pattern.  However, after 
the first bolus nutrient feed at 72 hours, the glucose metabolism for the cultures 
grown at 450 mosm/kg changed.  The glucose consumption rate for the 450 mosm/kg 
cultures leveled off between 72 and 122 hours, while the consumption rates for the 
other cultures remained similar to that during the batch phase.  This phenomenon 
was seen again between the second and third bolus feedings. 
The lactate trends during the batch phase (up to 72 hours) showed the expected 
response to the culture osmolality (Figure 5-4).  However, the trend for the 450 
mosm/kg culture deviated from the other trends after the first nutrient bolus feed.  The 
cultures grown at 450 mosm/kg began to consume lactate after receiving the nutrient 
rich feed.  This phenomenon was not noticed during the previous batch phase 
passages that were grown out to 88 hours (Figure 4-4 c.).  The drop in lactate levels 
for the other cultures corresponded to an increase in glucose concentration, thus less 
lactate was being made at this time.  This lactate trend, at an osmolality of 450 
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The pH of the culture medium is greatly affected by the lactate concentration (Figure 
5-5).  The cultures that produced the greatest amounts of lactate were found to have 
the largest drop in pH throughout the process.  The pH in the 450 mosm/kg culture 
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Figure 5-5:  Extra-cellular pH level during the fed -batch process 
 
Cells cultured at 450 mosm/kg were found to have a higher cell diameter throughout 
the fed-batch process.  This data is similar to that presented in Figure 4-7 for the 
batch cultures.  The initial drop in cell diameter after exposure to the hyper-osmotic 
condition was not witnessed during this experiment since the cultures were previously 
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Figure 5-6:  Osmolality effect on cell diameter dur ing the fed-batch process 
 
The specific productivity was found to increase with an increase in osmolality (Table 
5-2).  The 450 mosm/kg cultures had a 142% increase in productivity over the 
cultures grown at 290 mosm/kg.  The increase in osmolality, up to 400 mosm/kg, had 
a positive impact on the mAb concentration as well.  The 450 mosm/kg cultures saw 
a drop in mAb concentration on Day 11, with the concentration equaling that of the 
290 mosm/kg cultures.  This culture was extended an extra day due to the high 











Relative Average Day 
11 mAb 
Concentration 1 
290 1.00 1.00 
 3203 1.03 1.04 
350 1.12 1.12 
400 1.52 1.24 
450 2.43 1.00 (1.18 Day 12) 
1  The values presented in the table are relative to the value at the 290 mosm/kg condition. 
2  Value obtained from averaging the qAb for the duplicate flasks. 





Osmolality Effect on Growth and Viability 
 
The osmolality greatly affected the maximum VCD achieved in the cultures, as the 
cultures grown at hyper-osmotic conditions were found to produce the lowest 
maximum VCD (Figure 5-1).  These findings correlate with data presented by Wu 
(2004), who showed that an increase in medium osmolality negatively impacts the 
growth rate for a GS-NS0 cell line.   
The viability of the cultures for the fed-batch experiment was not affected by the 
increase in osmolality (Figure 5-2).  This was also shown during four passages in the 
batch phase experiments in Chapter 5 (Figure 4-2).  At 200 hours, the viability of the 
cultures grown at 450 mosm/kg remained high, while the viability began to decrease 
in all the remaining cultures (Figure 5-2).  The decrease in viability was possibly due 
to exhaustion of a non-measured nutrient (i.e. vitamin, amino acid, or trace element).  
All the cultures received a bolus of the nutrient rich proprietary feed at 170 hours 
(Day 7).  Since the 450 mosm/kg cultures were growing much slower than the other 
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cultures, it is possible that the nutrients were not exhausted, which allowed the 
viability of the culture to remain higher than the other cultures.   
The osmolality was shown to impact the cell diameter during the fed-batch process 
as well (Figure 4-7).  Cells cultured at 450 mosm/kg were found to have a higher cell 
diameter throughout the fed-batch process.  This data is similar to that presented in 
Figure 4-7 for the batch cultures and previous data from Ozturk, 1991. 
Osmolality Effect on Metabolism 
 
After the addition of the first bolus feed at 24 hours, the glucose and lactate trends for 
the 450 mosm/kg cultures experienced a different response from the other cultures.  
The glucose consumption rate decreased between the feed additions due to the 
slower growth rate (Figure 5-3) and the lactate concentration began to decrease in 
the culture, indicating that the cells were up taking lactate (Figure 5-4).   
Lactate is co-transported across the cell membrane with H+ ions through 
monocarboxylic transporters (MCTs).  Lactate transport is bidirectional and the 
lactate re-enters the cell accompanied with an H+ ion.  Lactate transport is highly pH 
sensitive and the uptake rate is faster when the external pH is lower (Hertz, 2004).  
Figure 5-5 showed that the external pH of the 450 mosm/kg cell culture was at its 
lowest (approximately 6.75) around the time the lactate level started to decrease.  
Due to the lower pH level lactate uptake could have been stimulated.   
Once the lactate has entered the cell, it can have multiple uses such as: 1. a 
substrate for the regeneration of glucose through the gluconeogenesis pathways, 2. 
conversion to pyruvate and enter the citric acid cycle becoming a precursor for amino 
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acid or fatty acid synthesis pathways, or 3. formation of osmolytes in response to 
RVI.   
In the absence of glucose, cells can utilize lactate as a carbon source.  Glucose can 
be synthesized from lactate through the gluconeogensis cycle, with lactate being first 
converted back to pyruvate by lactate dehydrogenase.  However, there was clearly 
enough glucose present in the culture, thus the cells were not requiring lactate to 
regenerate depleted glucose supplies.  Also, proteomic analysis of a CHO cell line in 
response to hyper-osmotic pressure by Lee (2003), showed that hyper-osmotic 
conditions promoted an up regulation of pyruvate kinase and glyceraldehydes-3-
phospate dehydrogenase.  Both of these enzyme drive glycolysis in the forward 
direction, thus the cell would not be exerting energy to reverse this process. 
The second fate of lactate in a cell is the conversion to pyruvate and entry into the 
citric acid cycle.  The citric acid cycle converts pyruvate into a myriad of intermediary 
compounds needed for the generation of amino acids or it can be converted to citrate 
and become a building block for fatty acid synthesis.  The cell cultures were all fed a 
proprietary nutrient rich feed, on day 3, 5, and 7 of the fed-batch experiment, which 
contained  protein hydrolysates that provide a surplus of amino acids.  Spent medium 
analysis showed that amino acid levels in all the cultures did not differ due to medium 
osmolality (data not presented).  However, metabolic profiling of the cultures (Chapter 
7) showed an increase in internal amino acid concentrations with increasing 
osmolality.   This indicates that the cultures do require either the uptake or generation 
of amino acids.  While Figure 7-2 shows that the increase in internal proline levels 
was seen in all cultures grown under osmotic pressure, the uptake of lactate was only 
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observed in the cultures grown at the highest osmotic pressure, 450 mosm/kg.  Thus, 
the demand for amino acid generation could be higher in the hyper-osmotic cultures, 
requiring the uptake of lactate.   
Lactate can also be a precursor for the generation of fatty acids and subsequently 
lipids (Patel, 1971).  Fatty acids are required for numerous functions in the cell.  Fatty 
acids are used in the building of the phospholipids bilayer of the cell membrane.  
Fatty acids are also essential for protein transport and cell signaling.   
The 450 mosm/kg culture had a much larger cell diameter than the other cultures 
(Figure 5-6).  The increased cell diameter would require the cell to need larger 
concentrations of phospholipids cell membrane than the cells grown at the lower 
osmotic media.  The uptake of lactate in the 450 mosm/kg cultures could be 
attributed to the larger cell diameter.  Previous data by Baquet (1991) suggested a 
stimulatory effect on cell swelling and lipid generation.  However, the metabolic 
profiling performed on these cultures did not see a response to fatty acid 
concentrations and osmotic pressure (Chapter 7).     
Lastly, cells introduced to increase osmolality experience RVI.  The cell accumulates 
electrolytes and osmolytes in order to regulate the cell volume after the initial 
decrease in size due to osmotic pressure.  Since electrolytes alter ion gradients and 
can compromise cell function, cells produce osmolytes which can alter the osmolality, 
and subsequently cell volume, without inhibiting cell function (Lang, 1998 a.).  
Mammalian cells produce three types of osmolytes: polyalcohols, methylamines, and 
amino acids and their derivatives.  The formation of methylamines, such as 
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glycerophosphorylcholine require the addition of fatty acids, thus generation of 
increased fatty acids would be required under hyper-osmotic conditions. 
Osmolality Effect on mAb Production 
 
The 450 mosm/kg culture also had a higher specific productivity than the other 
cultures, 60% higher than the cultures grown at 400 mosm/kg and 140% higher than 
the cultures grown at 290 and 320 mosm/kg (Table 5-2).  Proteomic analysis of GS-
NS0 cell cultures with varying mAb production rates was shown to have an 
upregulation of chaperone proteins required for protein synthesis, such as GRP78 
and PDI (Alete, 2005).  Alete (2005) also showed an upregulation of POR1 and 
POR2, porin proteins required for the formation of channels in the lipid bilayer for the 
transport of hydrophilic molecules.  An increase in pore formation as well as an 
increase in chaperone proteins would require an increased need of fatty acids and 
lipids.  Thus, the uptake of lactate in the 450 mosm/kg could be due to increased 
requirements of fatty acids due to the higher mAb specific productivity. 
The hyper-osmotic pressure did have a positive impact on the specific productivity of 
the cell line and these results correlate with the findings by Wu (2004) on a similar 
GS-NS0 cell line.  The 450 mosm/kg cultures did have the highest qAb, however, the 
decrease in growth rate lead to lower accumulation of viable cells and thus lower 
overall mAb concentration (Table 5-2).  This result is similar to findings by Ozturk 
(1991), Wu (2004), Oyaas (1994), and Lin (1999 b.), on a number of different cell 
lines.  The mAb concentration was found to increase with increasing osmolality up to 
the 400 mosm/kg condition.  For this cell line there appears to be a threshold for 
overall mAb produced between 400 and 450 mosm/kg. 
42 






Many industrial processes utilize a shift in a process parameter to stimulate mAb 
production.  A shift in temperature during mAb production has shown to maximize 
productivity in CHO cell lines (Fox, 2004; Kauffmann, 1998), while the response of a 
GS-NS0 cell line to pH shifts has been studied by Osman (2001).  To employ a 
process shift, the cell culture is first grown at one set of conditions which maximize 
cell growth rate.  Once the VCD of the culture is high, process parameters are 
adjusted to values that are conducive for high mAb production rates.   
The previous experiments (Chapters 5 and 6) have shown that the GS-NS0 cell line 
has a higher growth rate at lower osmolality medium and higher mAb productivity at 
higher osmolality levels.  Thus, it has been hypothesized whether a shift in medium 
osmolality could be beneficial for increased mAb production.  To test this hypothesis, 
cultures were grown at three different low osmolality conditions (290, 320, and 350 
mosm/kg) which were shown to promote high growth rates for this cell line (Chapter 
5).  The osmolality of the cultures was then shifted to 450 mosm/kg on either day 5 or 






Basal medium was prepared at 290, 320, and 350 mosm/kg, by adjusting the 
concentration of NaCl in the medium.  Synthetic cholesterol was added to the basal 
medium. 
A GS-NS0 cell culture, initially grown at approximately 300 mosm/kg, was obtained 
for use as an inoculum for this experiment.  The inoculum culture was added to each 
medium (290, 320, or 350 mosm/kg) at a starting VCD of 2.2 x 105 cells/mL.  The 
cultures were passaged into the respective medium three times before performing the 
fed-batch production experiment.  This was performed to acclimate the cells to the 
different osmolalities.  The fed-batch experiment started on the fourth passage.  The 
osmotic shift conditions for this experiment are illustrated in Table 6-1. 
Table  6-1. Growth c ondi tions for the osmolality shift e xperiments  
Shake Flask Number Growth Medium Osmolality, mosm/kg Osmotic Shift / Day 
1 and 2 290 None 
3 and 4 290 Day 5 
5 and 6 290 Day 7 
7 and 8 320 None 
9 and 10 320 Day 5 
11 and 12 320 Day 7 
13 and 14 350 None 
15 and 16 350 Day 5 
17 and 18 350 Day 7 
 
For the osmotic shift experiment, shake flasks were inoculated to a starting VCD of 
2.2 x 105 cells/mL.  On Days 3, 5, and 7 each shake flask received a bolus addition of 
the proprietary nutrient rich feed.  On Day 5 or 7, after the addition of the feed, the 
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osmolality of the shake flasks shown in Table 6-1 was adjusted to 450 mosm/kg by 
the addition of concentrated NaCl.  The cultures were all given a concentrated 
glucose feed to increase the glucose concentration to 2 g/L, if required, on Days 8 
through 10.  Note: some shake flasks did not receive a shift in osmolality and were 
maintained as control flasks for that osmotic condition. 
All the experiments were performed 250 mL shake flasks with a working volume of 
125 mL.  Operating conditions for the incubator were:  115 rpm for Day 0 – 3 and 160 
rpm for Day 3 - 11, 37oC, 80% relative humidity (rh), and 5% CO2.  The shaker 
agitation rate was increased after Day 3 to ensure adequate oxygenation to the cell 
cultures.  Each condition was performed in duplicate.   
Samples were taken daily to measure VCD, viability, glucose and lactate 
concentration, pH, and osmolality of the cultures.  The time course data was used to 
calculate the following metabolic parameters during exponential growth: glucose 
consumption rate, lactate production rate, and cellular growth rate. 
6.3 Results  
 
The osmotic shift to 450 mosm/kg had a great impact on the maximum VCD achieved 
in the experiment (Figure 6-1).  The cultures with the osmotic shift on Day 5 produced 
the lowest maximum VCD, while the cultures that did not experience an osmotic shift 
were capable of producing the highest maximum VCD.  Note: the VCD values in 
































290 290 - 450 on 5 290 - 450 on 7
320 320 - 450 on 5 320 - 450 on 7
350 350 - 450 on 5 350 - 450 on 7
 
Figure 6-1:  Osmolality shift effect on average VCD  
 
The viability of the cultures dropped after the shift in medium osmolality.  The 290 
mosm/kg cultures which had the greatest increase in osmolality on Day 5 were found 
to have the biggest drop in viability due to the osmotic shift (Figure 6-2).  Overall, the 
cultures that did have an osmotic shift had the highest viability at the end of the 
process.   Note: the viability values in Figure 6-2 are the average values for the 

















290 290 - 450 on 5 290 - 450 on 7
320 320 - 450 on 5 320 - 450 on 7
350 350 - 450 on 5 350 - 450 on 7
 
Figure 6-2:  Osmolality shift effect on average via bility 
 
The glucose (Figure 6-3) and lactate (Figure 6-4) concentrations showed a response 
to the medium osmolality.  During the batch phase (up to Day 3 / 72 hours), the 
cultures grown at 350 mosm/kg had the largest drop in glucose concentration and the 
largest production of lactate.  During the fed-batch phase, the glucose concentration 
was fairly consistent between conditions, except for the 290 → 450 on Day 5, which 
showed a slower consumption of glucose due to the reduced cell mass.  These 
cultures also had the highest lactate concentration, as expected since they received 
the largest change in osmolality.  The lactate concentration during the fed-batch 
phase showed great variability and concentrations cannot be correlated with a 




























290 290 - 450 on 5 290 - 450 on 7
320 320 - 450 on 5 320 - 450 on 7
350 350 - 450 on 5 350 - 450 on 7
 


























290 290 - 450 on 5 290 - 450 on 7
320 320 - 450 on 5 320 - 450 on 7
350 350 - 450 on 5 350 - 450 on 7
 
Figure 6-4:  Lactate trends for osmolality shift ex periments 
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The mAb concentration correlated with osmolality, as the shake flasks that did not 
receive an osmotic shift had increased final mAb concentration with increased 
medium osmolality (Table 6-2).  The osmotic shift was beneficial in increasing 
specific productivity and the cultures that received the shift in osmolality on Day 5 as 
opposed to Day 7 had the largest increase in qAb (Table 6-2).  The 350 → 450 on 
Day 5 cultures produced the highest mAb concentration.  Note:  the mAb 
concentration reported in Table 6-2 is the average concentration for the duplicate 
shake flasks. 
















due to Osmotic 
Shift, % 
290 1.00 NA 1.00 NA 
290 → 450 on Day 5 1.57 57.2 1.00 No Change 
290 → 450 on Day 7 1.19 19.3 1.02 1.89 
320 1.08 NA 1.10 NA 
320 → 450 on Day 5 1.41 32.7 1.21 9.4 
320 → 450 on Day 7 1.20 11.2 1.22 10.3 
350 1.29 NA 1.16 NA 
350 → 450 on Day 5 1.74 34.1 1.29 11.4 
350 → 450 on Day 7 1.59 23.1 1.25 8.1 
1  The value reported are relative to the value determined for the 290 mosm/kg condition. 







The osmotic shift was shown to reduce the maximum VCD of the cultures (Figure 
6-1).  This result was to be expected based on the growth rates calculated for the cell 
line in batch phase experiments (Table 4-1).  The cells grown at 450 mosm/kg were 
shown to have upwards of a 30% increase in growth rate over the cultures grown at 
the lower osmotic conditions.   
The osmotic shift also caused a considerable viability drop in the cultures, mainly the 
cultures grown at 290 mosm/kg (Figure 6-2).  However, the cultures that received the 
osmotic shift had the highest viability at the end of the process.  This result was also 
seen in the fed-batch experiments (Figure 5-2).  The 450 mosm/kg culture was still 
over 80% viable on Day 11.  The slower growth rate caused by the osmotic shift can 
contribute to the higher viabilities of these cultures.  It is possible that a non-
measured nutrient had exhausted in the cultures with the higher viable cell densities, 
apparent from the crash in viability, beginning on Day 10, for the cultures that did not 
receive an osmotic shift (Figure 6-2). 
The purpose of these experiments was to test if an osmotic shift would positively 
impact productivity and this was found to be true.  The cultures grown at 350 
mosm/kg, which received the osmotic shift, were found to be the highest producers of 
mAb (Table 6-2).  Based on the previous data from the batch and fed-batch 
experiments, this finding could have been predicted.  The batch phase experiments 
(Table 4-2) showed that the optimum osmolality for cell growth was 350 mosm/kg and 
the fed-batch experiments showed that the optimum osmolality for protein production 
was 450 mosm/kg (Table 5-2).  Thus, the cells were grown in the most conducive 
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osmolality condition for growth prior to shifting to the most conducive condition for 
protein production.   
The timing of the osmotic shift was found to impact the productivity and mAb 
concentration.  The cultures which received the shift in osmolality on Day 5 as 
opposed to Day 7 had a higher increase in both qAb and mAb concentration (Table 
6-2).  Further optimization into the timing of the osmotic shift could prove to be 


















As stated in section 2.3, the application of metabolomics to mammalian cell culture 
has not been widely explored.  Techniques used to quench the metabolism of 
microbial and yeast cell lines, might not be sufficient to stop the metabolism of 
mammalian cell cultures.  Errors in sampling and quenching can lead to an 
inaccurate representation of the metabolic profile of these cell lines.  Advances such 
as a micro heat exchanger to rapidly sample and quench mammalian cells are 
currently being developed (Wiendahl, 2007).   
In this work, quenching cells by snap-freezing in liquid nitrogen was used.  This 
method is similar to that used by Griffin (2000), et al. in their work with rodent cell 
culture samples.  Extraction was performed using a methanol/water method 
previously developed for potato tuber cultures (Roessner, 2000).  Derivatization of 
the polar metabolites was performed using methods described by Dutta (2009) for 
Arabidopsis thalia.  Identification and quantification of the derivatized metabolites was 
performed using a GC-MS method and data analysis method previously described by 
Kanani and Klapa (2007). 
The metabolomics methods referenced above were evaluated for use on the GS-NS0 
cell line.  Finger printing of the GS-NS0 metabolic response to osmolality was 




Quenching, Extraction, and Derivatization 
 
Cells were removed from the shake flask experiments performed in Chapters 4 (81 
hours, Passage 3 / Day 4) and 6 (72 hours, Passage 4 / Day 3 and 144 hours, 
Passage 4 / Day 6) and were washed and centrifuged (Sorvall Model, 1000 g for 5 
minutes) in ice cold phosphate buffer (pH 7.0) to remove the spent medium and 
external metabolites.  After washing, the cell pellets were snap frozen in an ethanol / 
dry ice bath to quench metabolism and remained in the bath during cell lysis 
manipulations.  A 0.2 mg of ribitol per gram of cell mass was added to each sample 
(ribitol was used as an internal standard for the extraction and derivatization assay).  
Cold methanol stored in dry ice (28 mL / g of cells) was added to each sample to 
extract metabolites while the cells were homogenized using a tissue grinder.   
The homogenized cells in the methanol mixture were heated to 70oC for 15 minutes 
in a water bath.  After heating, water was added to each sample and the suspension 
was centrifuged at 4000 g for 10 minutes.  The supernatant containing the internal 
metabolites was removed and aliquoted into glass tubes.  The metabolite samples 
were then vacuum dried over night at room temperature.  After drying, the samples 
were stored at -20oC until derivatization.   
The metabolites were converted to their methoxime trimethyl-silyl derivatives. The 
derivatization was carried out in two steps.  First 100 µL of methoxyamine 
hydrochloride solution in pyridine (20 mg/mL) was added to each of the dried 
extracted samples.  The samples were incubated at room temperature for 120 
53 
minutes.  Next, 100 µL of silylating agent, MSTFA (N-Methyl-N-(trimethylsilyl) 
trifluoroacetamide) was added and the samples were incubated for four hours.  Fifty 
µL of the derivatized metabolite solution were then placed into GC-MS autosampler 
vials. 
 
Metabolite Identification and Analysis 
 
The samples were analyzed using a Varian 2000 GC-(ion trap) MS system run using 
a previously established GC-MS metabolomic methods (Kanani and Klapa) (40:1 split 
ratio, 1 mL/min column flow rate, and 3 scans per sec scanning rate using 1 µL of the 
injected derivatized solution).  Optimization of the split ratio was performed to ensure 
all peaks, except phosphate, were below the saturation region and within the linear 
operating range of the instrument.  A high concentration of phosphate was present in 
the samples due to residual phosphate buffer used for washing the cells when 
removing the extracellular metabolites.  The GC-MS temperature program was as 
follows: hold 70oC for 5 min, 5o/min heating ramp up to 320oC, and hold for 1 min at 
320oC; thus the total run time of the GC-MS run was about 55-57 minutes. Two 
instrument replicates were run for each biological sample.  
The raw data obtained from GC-MS analysis was processed using Varian instrument 
software and data processing methods for peak quantification developed by 
researchers at University of Maryland, College Park (UMCP). Peaks were identified 
by using (1) an in house library of standard metabolites, (2) NIST mass spectrometry 
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library, and (3) publicly available GC-MS standard libraries. The raw peak areas 
obtained for each metabolite were then normalized using a proprietary data 
correction and normalization algorithm developed by researchers at UMCP (Kanani 
and Klapa, 2007).  Multivariate data analysis was performed on the normalized peak 
areas using open source freely available Multi Experiment Viewer (MeV) software.  
Metabolite quantification and data analysis was performed by Harin Kanani under the 
direction of Dr. Maria Klapa, Chemical and Biomolecular Engineering Department, 
University of Maryland, College Park. 
 
7.3 Results  
 
Figure 7-1 shows a typical GC-MS profile for a cell culture sample.  The x-axis is the 
retention time and y-axis is the total ion intensity recorded by the mass-spectrometer 
at the given retention time. In order to overcome the problem of co-eluting peaks, 
unique m/z and retention time combinations were used for quantification of individual 
metabolites. 650 metabolite derivative peaks were detected in at least one of the 
samples, but after filtering, data correction, and normalization only 170 consistent 
metabolites were used for data analysis.  From these, 63 metabolites were with 
known structure and another 20 metabolites had at least partial classification. The 
rest of the metabolites could not be identified based on existing databases.  Table 7-1 
lists the metabolites that were consistently identified in the cell culture samples. 
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Figure 7-1:   A GC-MS metabolomic profile of a typi cal cell culture sample 
 




6-Hydroxynicotinate, Adenoise, Allothreonine, Asparagine, 
Aspartate, b-Alanine, Cystine, Ethanolamine, Glutamine, 
Histidine, Isoleucine, Indole, Leucine, Lysine, Methinonine, 
N-acetylglutamate, Ornithine+Arginine, Phenylalanine, 
Proline, Serine, Threonine, Uracil 
Sugars  Arabinose, Arabinofuranose / Ribofuranose, Erythritol, 
Fructose, Fructose-6-Phosphate, Glucose, Maltose, myo-
Inositol, myo-Inositol-(1 or 2)-phosphate, Rhamnose, 
Sorbitol, Xylitol 
Organic Acids  2-bis-Hydroxybutanoic Acid, 2-hydroxybutanoic Acid, 2-
Hydroxyglutarate, 4-Hydroxybutanoic Acid, Citramalate, 
Citrate, Fumarate, Gluconate, Glycerate, Glycolate, 
Glyoxilate, Malate, Pyrrole-2-carboxylic Acid, Pyruvate, 
Succinate, Threonate 
Lipid Components  α-Linolenic Acid, Glycerol, Glycerol-2-phosphate, Glycerol-3-
phosphate, 3-Phospho-glycerate, Monomethylphosphate, 
Octadecanoic Acid, Phosphoric Acid 
Secondary 
Metabolites 




Figure 7-2 shows an example of the GC-MS metabolomic data peak identification 
and relative quantification.  The profile is from a sample taken at the end of the batch 
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Figure 7-2:  Comparison of proline peak under diffe rent osmolality conditions 
 
The data was normalized to the metabolomic profile of 290 mosm/kg for each of the 
three sample times obtained and averaged for two biological and two instrumental 
replicates.  A clear separation between the metabolomic profiles of passage 3 / day 4 
(end of batch phase; green), passage 4 / day 3 (end of batch phase; red) and 
passage 4 / day 6 of mAb production process (blue) profiles is shown in Figure 7-3.  
This suggests the passage and age of the culture has a strong influence on 
concentration of metabolites – which is stronger than the effect of different osmolality. 
Within the three sample groups however, it can be seen that the 400 mosm/kg 
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clusters with 450 mosm/kg. Thus, there seems to be a significant jump in 
metabolomic profiles between concentration 350 and 400 mosm/kg. 
 
 
Figure 7-3:  Heat map of the hierarchical clusterin g of average normalized 
samples 
 
A cluster of 22 metabolites (9 known) were identified, which showed significant 
increase (up to 50 fold) between the high osmolality and low osmolality conditions. In 
spite of differences between the passage and age of the culture, these metabolites 
showed a consistent increase, almost proportional, to the osmolality suggesting a 
very strong link to the osmotic response of the cultures (Figure 7-4). 
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Figure 7-4:  K-means clustering of the averaged met abolomic profiles. 
 
A heat map of the cluster of metabolites identified in Figure 7-4 is shown in Figure 









Despite using quenching and extraction steps developed for plant cell cultures, a 
dose response in the NS0 cell culture to medium osmolality was found.  Proline 
concentrations were shown to increase as the osmolality of the medium increased 
(Figure 7-2).  Proline can be used by the cell as an osmolyte in order to return the cell 
to its original volume when experiencing a regulatory cell volume increase due to 
hyper-osmotic conditions (Lang 1998 a.)  Since the cells grown at 450 mosm/kg were 
found to be the largest after RVI, an increase in osmolytes, such as proline, would be 
required. 
60 
The cell age or stage of the fed-batch process, was found to have a stronger 
influence on the metabolite concentration than the medium osmolality (Figure 7-3).  
This finding was to be expected as the cellular environment differs drastically due to 
metabolites present in the batch vs. nutrient rich feed medium during a fed-batch 
process.  The basal batch medium is a very basic medium that does not contain a 
large quantity of amino acids, while the nutrient rich feed contains large 
concentrations of amino acids and small polypeptides.  The passage number also 
had a strong influence on the metabolite concentration (Figure 7-3).  It would be 
predicted that samples taken at the end of the batch phase in both passage 3 and 4 
would have similar concentrations in metabolites.  However, the growth, glucose 
uptake, and lactate production rates were found to differ between passages (Figure 
4-3, Figure 4-5, and Figure 4-6).  These differences would lead to dissimilar 
metabolite concentrations. 
A cluster of 22 metabolites were found to significantly increase with increasing 
osmolality (Figure 7-4).  Nine of these metabolites were identified including multiple 
amino acids and their derivatives were present in higher concentrations in the cells 
grown under hyper-osmotic conditions.  As stated above, amino acids and their 
derivatives are used as osmolytes to help cell’s regulate their volume in hyper-





Chapter 8 Conclusions 
 
 
The osmolality of the growth medium was shown to greatly impact the cell growth and 
metabolism of the GS-NS0 cell line evaluated.  Growth medium at 350 mosm/kg was 
found to be optimum for cellular growth rate, while 450 mosm/kg medium was found 
to be optimum for specific productivity of the monoclonal antibody.   The metabolism 
was affected by the change in medium osmolality.  Glucose uptake and lactate 
production rates increased with increasing osmolality.  In fed-batch cultures grown at 
450 mosm/kg, cellular uptake of lactate was witnessed.  It is hypothesized that the 
lactate uptake was due to the increased mAb productivity rate and the increased cell 
size of these cultures.  Lactate can be utilized by the cell in the production of fatty 
acids.  Additional fatty acids would be required by cells with increased protein 
productivity and increased cell diameter.   
The GS-NS0 cell line showed cell volume regulatory mechanisms.  When the cells 
were first introduced to hyper-osmotic medium, the cells initial shrunk as a result of 
the osmotic pressure gradient created.  However, the cells were able to increase their 
cell size through RVI mechanisms and return to a more normal cell size.  RVI 
requires the formation of osmolytes in the cell in order to alter the osmolality without 
affected cellular function.  Metabolic analysis of the cells found that the common 
osmolytes, proline, was higher in cells cultured under hyper-osmotic conditions.   
The mAb productivity was greatly increased with an increase in medium osmolality.  
Cells grown at 450 mosm/kg were found to have a 140% increase in productivity over 
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those grown at 290 or 320 mosm/kg.  However, due to lower cellular growth rates, 
the total mAb produced did not increase at hyper-osmotic conditions.  Antibody 
concentrations were found to be at a maximum in the cultures grown at 400 
mosm/kg; at 450 mosm/kg the mAb concentration dropped almost 20%.   
An osmotic shift proved to be beneficial in increasing the antibody concentration in 
the cell culture.  Cells initially grown at 350 mosm/kg and then shifted to 450 
mosm/kg were found to produce the highest concentration of mAb.  The osmotic shift 
increased qAb for all conditions evaluated and qAb was found to be dependent on the 
timing of the osmotic shift.   
The metabolomic analysis of the GS-NS0 cell line showed a dose response in the 
internal concentration of amino acids and their derivatives.  Proline concentrations 
were found in increasing concentration in the cells grown under hyper-osmotic 








Chapter 9 Future Studies 
 
 
The research on the response of the GS-NS0 cell line has just scratched the surface.  
Osmolality has been shown to greatly impact the metabolism of the cell, however little 
is still known on the mechanisms of its impact.  Lactate was found to be up taken into 
the cell in cultures grown under hyper-osmotic conditions, however, the fate of the 
lactate is unknown.  It has been postulated that lactate could be used for the 
formation of amino acids, osmolytes, or fatty acids.  The metabolic profiling 
performed on the cultures was inconclusive in determining the fate of lactate.  Further 
analysis using tools such as metabolomics and proteomics can provide a vast insight 
into the utilization of lactate in osmotically stressed cells.  Additional experimentation, 
such as oil red O staining, could help in determining an increase in fatty acid 
concentrations on the surface of cells grown under hyper-osmotic conditions.   
Additionally, cultures grown under hyper-osmotic conditions showed an increase rate 
of glucose consumption.  The increase in glucose uptake was did not contribute to an 
increase in cell concentration for these cultures.  The increase in glucose 
consumption could be due to a higher energy demand for the culture.  A carbon mass 
balance to quantify the CO2 formation from the cell culture under different osmotic 
conditions could be performed to analyze the energy requirements of these cultures.    
Furthermore, hyper-osmotic conditions are favorable for the production of monoclonal 
antibodies.  It is still not clearly understood why osmotically stressed cells are better 
mAb factories.  Finding the reasons to how cells can increase their productivity will 
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provide beneficial in the engineering of new industrial cell lines.  Furthermore, 
osmotic shifts were found to be beneficial in increasing mAb concentrations.  
Increasing the yield of mAb during cell culture processes is one of the main goals of 
process development efforts in biopharmaceutical companies.  Further optimization 
of the medium osmolality and timing of osmotic shifts would be an economical means 
of increasing mAb for industrial production. 
The application of metabolomics to the cell culture field has a lot of potential for 
growth and future studies.  The development of an easy and controlled quenching 
procedure to quickly cease cellular metabolism is a must to ensure true data 
collection when monitoring intracellular metabolites.  In addition, improvements to 
separation techniques and metabolite databases, to accurately evaluate and identify 
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